Lviv Regional Central Hospital

Lviv 79010

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease — Completed